Search Results - "Galoian, Karina A."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Regulation of onco and tumor suppressor MiRNAs by mTORC1 inhibitor PRP-1 in human chondrosarcoma by Galoian, Karina A., Guettouche, Toumy, Issac, Biju, Qureshi, Amir, Temple, H. T.

    Published in Tumor biology (01-03-2014)
    “…Metastatic chondrosarcoma of mesenchymal origin is the second most common bone malignancy and does not respond either to chemotherapy or radiation; therefore,…”
    Get full text
    Journal Article
  2. 2

    Cytostatic effect of novel mTOR inhibitor, PRP-1 (galarmin) in MDA 231 (ER−) breast carcinoma cell line. PRP-1 inhibits mesenchymal tumors by Galoian, Karina A., Temple, Thomas H., Galoyan, Armen

    Published in Tumor biology (01-08-2011)
    “…Activation of the PI3K–Akt–mTOR pathway is implicated both in the establishment of tumors and as well as a target for therapy in many types of solid…”
    Get full text
    Journal Article
  3. 3

    Utility of Quantitative Computerized Pain Drawings in a Sample of Spinal Stenosis Patients by Felix, Elizabeth Roy, Galoian, Karina A., Aarons, Chad, Brown, Mark D., Kearing, Stephen A., Heiss, Uwe

    Published in Pain medicine (Malden, Mass.) (01-03-2010)
    “…Objective.  To evaluate the utility of quantitative computerized pain drawings (CPDs) in a sample of spine patients before and after surgery. Design.  Analysis…”
    Get full text
    Journal Article